ID   LN-1049
AC   CVCL_LI20
DR   Wikidata; Q54902767
RX   PubMed=2989064;
CC   Population: Japanese.
CC   Doubling time: 36 hours (PubMed=2989064).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=2989064).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LI21 ! PB-1049
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 12
//
RX   PubMed=2989064; DOI=10.20772/cancersci1985.76.5_365;
RA   Yamada T., Sasaki M., Yoshida M.C., Aya T., Koizumi S., Osato T.;
RT   "Establishment and characterization of Ph1-positive and Ph1-negative
RT   lymphoblastoid cell lines from a patient with chronic myelogenous
RT   leukemia.";
RL   Jpn. J. Cancer Res. 76:365-373(1985).
//